Multicentric Reticulohistiocytosis (MRH)
Multicentric reticulohistiocytosis (MRH) is an extremely rare systemic disease in the non-Langerhans cell histiocytosis group. It is marked by abnormal infiltration of the skin, joint synovium and internal organs by multinucleated macrophages with "ground-glass" cytoplasm.
Although the early skin lesions can look harmless, resembling xanthomas or psoriasis, MRH can cause extensive, destructive joint damage (arthritis mutilans) and is closely associated with systemic malignancy (about 15%–30% of cases present as a paraneoplastic syndrome).
At Haute-Derma, recognizing the characteristic skin signs of MRH, especially the "coral bead" sign, is a key diagnostic step that helps prevent permanent joint deformity and allows early screening for hidden internal cancers.
Characteristic Clinical Features of MRH
MRH most often affects middle-aged women (female-to-male ratio about 3:1), with skin and joint disease occurring together:
- Characteristic Skin Lesions:
- "Coral bead" sign: Small red, pink or reddish-brown papules (1–2 mm) lined up along the folds around the fingernails or toenails (periungual folds). This is the most telling clinical sign of MRH.
- Xanthoma-like papules and nodules: Smooth, firm, red-yellow or gray-brown papules on the face, ears, neck, chest and the extensor surfaces of the knuckles and finger joints.
- Facial changes: Histiocytic infiltration of facial skin can produce a mild "lion-like" appearance (leonine facies), and nodules in the oral mucosa or vocal cords can cause hoarseness.
- Progressive Destructive Polyarthritis:
- Begins symmetrically in the small joints of the hands, especially the distal interphalangeal (DIP) joints, which are usually spared in rheumatoid arthritis.
- About 45% of patients progress to arthritis mutilans, with extensive bone resorption (osteolysis) that shortens the fingers and produces the telescoping "opera-glass hand" (main en lorgnette).
- Systemic Features and Associated Cancer:
- Low-grade fever, fatigue, weight loss and muscle weakness.
- A raised risk of internal cancer (lung, breast, stomach, ovary, prostate or blood cancers), often found within 12 months of the MRH skin papules appearing.
Diagnosis and Clinical Management at Haute-Derma
When a patient presents with red-brown papules over the joints along with painful, deforming fingers, Haute-Derma follows a standardized assessment:
Dermoscopy and Skin Biopsy
- Dermoscopy: A yellow-orange to brick-red background (from lipid and macrophage accumulation) with branching dilated vessels at the periphery.
- Skin biopsy (confirms the diagnosis):
- A dense dermal infiltrate of mononuclear histiocytes and multinucleated giant cells.
- The cytoplasm has a characteristic pale pink, eosinophilic ground-glass appearance.
- Immunohistochemistry: CD68 (+), CD163 (+), factor XIIIa (+); CD1a (−) and S100 (−), which helps exclude Langerhans cell histiocytosis.
Contraindications and Skin Care
- No invasive cosmetic procedures: Laser, chemical peels, mesotherapy and microneedling must not be performed on MRH papules. Any mechanical injury can trigger the Koebner phenomenon and poorly healing skin necrosis.
- Gentle care: Use a barrier-repair moisturizer and broad-spectrum sunscreen, and monitor the periungual lesions closely.
Multidisciplinary Referral
MRH cannot be managed in a dermatology clinic alone. Patients need urgent joint review with rheumatology and oncology:
- Systemic immunosuppression: Combinations of systemic corticosteroids, methotrexate, cyclophosphamide or anti-TNF-alpha biologics (infliximab, adalimumab) to halt progressive bone and joint destruction.
- Comprehensive cancer screening: PET-CT, CT of the chest, abdomen and pelvis, GI endoscopy and tumor markers to rule out a hidden internal tumor.
